Philadelphia’s mass tort litigation over recalled heartburn medication Zantac has surged to encompass over 600 cases as plaintiffs lawyers across the U.S. opt to file suits in state court rather than in the federal multidistrict litigation.

The Zantac program is now the largest of four mass torts to have been established in Philadelphia’s Complex Litigation Center in 2022. The litigation’s 640-case docket dwarfs the other three programs, which each have case lists hovering between 120 and 150, according to the court’s website.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]